Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
CzechiaStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
AustriaStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
GermanyStudy on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
FranceStudy on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
AustriaStudy on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
AustriaStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
HungaryStudy of the safety and effectiveness of TRIV-573 injections in adults with moderate to severe atopic dermatitis
CzechiaDiagnostic PET/CT Study with [AL[18F]F]FAPI-74 in Psoriasis Patients with Arthralgia for Early Detection of Psoriatic Arthritis
BelgiumAssessing the efficacy and safety of nemolizumab in patients aged 12 years or older with dystrophic epidermolysis bullosa
FranceA Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
